ArticleFrontiers in immunology2022

A Whole Exon Screening-Based Score Model Predicts Prognosis and Immune Checkpoint Inhibitor Therapy Effects in Low-Grade Glioma.

Cheng Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.